Status:
COMPLETED
Individualized Automatic Target Coaching Message for Glycemic Management and Depressive Symptom
Lead Sponsor:
Samsung Medical Center
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
20-69 years
Phase:
NA
Brief Summary
This is a single-center, randomized, prospective, feasibility and acceptability trial in patients with type 1 diabetes. For six weeks, the intervention group will receive weekly personalized coaching ...
Eligibility Criteria
Inclusion
- Patients who are determined to use continuous glucose monitoring based on their physician's medical judgment.
- Patients with type 1 diabetes, age 20-69 years old
- Currently receiving treatment with multiple insulin injection therapy
- Patients who have access to KakaoTalk via smartphone and are able to communicate with it
- Voluntarily agreed to participate in this clinical study.
Exclusion
- Subjects using oral hypoglycemic agents
- Steroid and immunosuppressant users
- Subjects receiving anticancer medications
- Breastfeeding or pregnant patients
- Patients who do not voluntarily consent to the study
- Anyone deemed unsuitable by the investigator to participate in the study
Key Trial Info
Start Date :
August 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06525454
Start Date
August 7 2024
End Date
September 30 2024
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea